- Report
- October 2023
- 190 Pages
Global
From €4655EUR$4,900USD£3,992GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Clinical Trials
- April 2024
- 230 Pages
Global
From €2850EUR$3,000USD£2,444GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1188EUR$1,250USD£1,018GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£1,018GBP
- Drug Pipelines
- February 2024
- 180 Pages
Global
From €2850EUR$3,000USD£2,444GBP
- Report
- January 2024
- 161 Pages
Global
From €2375EUR$2,500USD£2,037GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €1900EUR$2,000USD£1,629GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1425EUR$1,500USD£1,222GBP
- Report
- November 2023
- 188 Pages
Global
From €7125EUR$7,500USD£6,110GBP
- Report
- January 2024
- 143 Pages
Global
From €4038EUR$4,250USD£3,462GBP
- Report
- January 2024
- 200 Pages
Global
From €3943EUR$4,150USD£3,381GBP
- Report
- January 2024
- 170 Pages
Global
€4745EUR$4,995USD£4,069GBP
- Report
- March 2021
- 207 Pages
Global
From €4559EUR$4,799USD£3,909GBP
- Report
- May 2023
- 123 Pages
Global
From €5653EUR$5,950USD£4,847GBP
- Report
- May 2024
- 129 Pages
From €6174EUR$6,499USD£5,294GBP
- Report
- May 2024
- 140 Pages
From €6174EUR$6,499USD£5,294GBP
- Report
- November 2022
- 140 Pages
Global
From €2366EUR$2,490USD£2,028GBP
- Report
- July 2023
- 136 Pages
China
From €1710EUR$1,800USD£1,466GBP
Progesterone is a hormone that plays an important role in women's health. It is produced by the ovaries and is essential for the regulation of the menstrual cycle, fertility, and pregnancy. Progesterone is also used to treat a variety of conditions, including abnormal uterine bleeding, endometriosis, and premenstrual syndrome. It is available in a variety of forms, including oral tablets, topical creams, and injections.
The progesterone market is an important part of the women's health industry. It is driven by the increasing prevalence of conditions such as endometriosis and premenstrual syndrome, as well as the growing demand for hormone replacement therapy. The market is also influenced by the availability of new products and technologies, such as transdermal patches and vaginal rings.
Some companies in the progesterone market include Pfizer, Merck, AbbVie, and Novo Nordisk. Show Less Read more